Acta Med. 2012, 55: 165-171

https://doi.org/10.14712/18059694.2015.41

Hyperleptinemia as a Prognostic Factor for Preeclampsia: a Cohort Study

Hugo Mendieta Zeróna, Verónica Jackeline García Soloriob, Pamela Montserrat Nava Díazc, Adriana Garduño Alanísc, Jonnathan Guadalupe Santillán Benítezd, Victoria Domínguez Garcíad, Carolina Escobar Brionese, Edgar Denova Gutiérrezf

aMolecular Biology Laboratory, Medical Research Center (CICMED), Autonomous University of the State of Mexico (UAEMex), Toluca, México
bAutonomous University of the State of Mexico, Toluca, Mexico
cMaternal-Perinatal Hospital “Monica Pretelini”, Toluca, Mexico
dMedical Research Center, Autonomous University of the State of Mexico, Toluca, Mexico
eFaculty of Medicine, National Autonomous University of Mexico
fNational Institute of Public Health (INSP), Cuernavaca, Morelos, Mexico

Received June 20, 2012
Accepted December 29, 2012

References

1. Tsoi E, Shaikh H, Robinson S, Teoh TG. Obesity in pregnancy: a major healthcare issue. Postgrad Med J 2010; 86: 617–23. <https://doi.org/10.1136/pgmj.2010.098186>
2. Ostlund I, Hanson U, Bjorklund A, et al. Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care 2003; 26: 2107–11. <https://doi.org/10.2337/diacare.26.7.2107>
3. Ray JG, Berger H, Lipscombe LL, Sermer M. Gestational prediabetes: a new term for early prevention? Indian J Med Res 2010; 132: 251–5.
4. Kuc S, Wortelboer EJ, van Rijn BB, et al. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 2011; 66: 225–39. <https://doi.org/10.1097/OGX.0b013e3182227027>
5. Bienertova-Vasku J, Dostalova Z, Kankova K, et al. Is there any link between severe pre-eclampsia and defined polymorphisms in leptin and adiponectin genes? J Obstet Gynaecol Res 2008; 34: 858–64. <https://doi.org/10.1111/j.1447-0756.2008.00794.x>
6. Ouyang Y, Chen H, Chen H. Reduced plasma adiponectin and elevated leptin in pre-eclampsia. Int J Gynaecol Obstet 2007; 98: 110–4. <https://doi.org/10.1016/j.ijgo.2007.04.021>
7. Molvarec A, Szarka A, Walentin S, et al. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol 2011; 9: 124. <https://doi.org/10.1186/1477-7827-9-124> <PubMed>
8. Rigo J, Szendei G, Rosta K, et al. Leptin receptor gene polymorphisms in severely pre-eclamptic women. Gynecol Endocrinol 2006; 22: 521–5. <https://doi.org/10.1080/01674820600915502>
9. Nagy B, Varkonyi T, Molvarec A, et al. Leptin gene (TTTC)(n) microsatellite polymorphism in pre-eclampsia and HELLP syndrome. Clin Chem Lab Med 2009; 47: 1033–7. <https://doi.org/10.1515/CCLM.2009.243>
10. Varkonyi T, Lazar L, Molvarec A, et al. Leptin receptor (LEPR) SNP polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analysis. BMC Med Genet 2010; 11: 25. <https://doi.org/10.1186/1471-2350-11-25> <PubMed>
11. http://www.imim.es/ofertadeserveis/software-public/granmo/. 2011.
12. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1–S22.
13. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979; 28: 1039–57.
14. Balas-Nakash M, Rodríguez-Cano A, Muñoz-Manrique C, Vásquez-Peña P, Perichart- Perera O. [Adherence to a medical nutrition therapy program in pregnant women with diabetes, measured by three methods, and its association with glycemic control]. Rev Invest Clin 2010; 62: 235–43.
15. Nakatsukasa H, Masuyama H, Takamoto N, Hiramatsu Y. Circulating leptin and angiogenic factors in preeclampsia patients. Endocr J 2008; 55: 565–73. <https://doi.org/10.1507/endocrj.K07E-136>
16. Paradisi G, Ianniello F, Tomei C, et al. Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes. Gynecol Endocrinol 2010; 26: 539–45. <https://doi.org/10.3109/09513591003632084>
17. Retnakaran R, Connelly PW, Maguire G, et al. Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes. Diabet Med 2007; 24: 245–52. <https://doi.org/10.1111/j.1464-5491.2007.02077.x>
18. Retnakaran R, Qi Y, Connelly PW, et al. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia 2010; 53: 268–76. <https://doi.org/10.1007/s00125-009-1600-8> <PubMed>
19. Geary M, Pringle PJ, Persaud M, et al. Leptin concentrations in maternal serum and cord blood: relationship to maternal anthropometry and fetal growth. Br J Obstet Gynaecol 1999; 106: 1054–60. <https://doi.org/10.1111/j.1471-0528.1999.tb08113.x>
20. Lepercq J, Cauzac M, Lahlou N, et al. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 1998; 47: 847–50. <https://doi.org/10.2337/diabetes.47.5.847>
21. Dalamaga M, Srinivas SK, Elovitz MA, Chamberland J, Mantzoros CS. Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case-control study. Metabolism 2011; 60: 1539–44. <https://doi.org/10.1016/j.metabol.2011.03.021> <PubMed>
22. Martínez-Abundis E, González-Ortiz M, Pascoe-González S. Serum leptin levels and the severity of preeclampsia. Arch Gynecol Obstet 2000; 264: 71–3. <https://doi.org/10.1007/s004040000081>
23. Laivuori H, Gallaher MJ, Collura L, et al. Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia. Mol Hum Reprod 2006; 12: 551–6. <https://doi.org/10.1093/molehr/gal064>
24. Chan TF, Su JH, Chung YF, et al. Elevated amniotic fluid leptin levels in pregnant women who are destined to develop preeclampsia. Acta Obstet Gynecol Scand 2006; 85: 171–4. <https://doi.org/10.1080/00016340500460615>
25. Highman TJ, Friedman JE, Huston LP, Wong WW , Catalano PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1998; 178: 1010–5. <https://doi.org/10.1016/S0002-9378(98)70540-X>
26. Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 2009; 16: 921–37. <https://doi.org/10.1177/1933719109336614>
27. Ge YC, Li JN, Ni XT, et al. Cross talk between cAMP and p38 MAPK pathways in the induction of leptin by hCG in human placental syncytiotrophoblasts. Reproduction 2011; 142: 369–75. <https://doi.org/10.1530/REP-11-0053>
28. Maymo JL, Pérez PA, Dueñas JL, et al. Regulation of placental leptin expression by cyclic adenosine 5′-monophosphate involves cross talk between protein kinase A and mitogen-activated protein kinase signaling pathways. Endocrinology 2010; 151: 3738–51. <https://doi.org/10.1210/en.2010-0064>
29. Sánchez-Jiménez F, Pérez-Pérez A, González-Yañes C, Varone CL, Sánchez-Margalet V. Sam68 mediates leptin-stimulated growth by modulating leptin receptor signaling in human trophoblastic JEG-3 cells. Hum Reprod 2011; 26: 2306–15. <https://doi.org/10.1093/humrep/der187>
30. Lu D, Yang X, Wu Y, et al. Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia. Int J Gynaecol Obstet 2006; 95: 121–6. <https://doi.org/10.1016/j.ijgo.2006.06.015>
31. Gao XL, Yang HX, Zhao Y. Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J (Engl) 2008; 121: 701–5. <https://doi.org/10.1097/00029330-200804020-00008>
32. Roberts JM, Bodnar LM, Patrick TE, Powers RW. The Role of Obesity in Preeclampsia. Pregnancy Hypertens 2011; 1: 6–16. <https://doi.org/10.1016/j.preghy.2010.10.013> <PubMed>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive